Reversal of multi-drug resistance by vector-based-ShRNA-Mdr1 in Vitro and in Vivo

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 5, 2009, Pages 620-624

  Lu, Shi ^a   Huang, Qi ^a   Wang, Zehua ^a   Song, Yinfeng ^a   Wang, Lijun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gene therapy; Multi drug resistance; RNA interference

Indexed keywords

ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; MULTIDRUG RESISTANCE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70350654517     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0517-2     Document Type: Article

References (22)

1. H. Thomas H.M. Coley 2003 Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein Cancer Control 10 2 159 165 12712010
2. T.W. Loo D.M. Clarke 2005 Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux J Membr Biol 206 3 173 185 16456713 10.1007/s00232-005-0792-1 1:CAS:528:DC%2BD28XhtFWmsbk%3D (Pubitemid 43199136)
3. R.Z. Yusuf Z. Duan D.E. Lamendola, et al. 2003 Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation Curr Cancer Drug Targets 3 1 1 19 12570657 10.2174/1568009033333754 1:CAS:528:DC%2BD3sXlsVGntg%3D%3D (Pubitemid 36119417)
4. I.B. Roninson J.E. Chin K.G. Choi, et al. 1986 Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells Proc Natl Acad Sci USA 83 12 4538 4542 3459187 10.1073/pnas.83.12.4538 1:CAS:528: DyaL28XksFGmu70%3D
5. U. Masanek G. Stammler M. Volm 2002 Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides J Exp Ther Oncol 2 1 37 41 12415618 10.1046/j.1359-4117.2002.01004.x 1:CAS:528:DC%2BD38XosVCqtr4%3D (Pubitemid 34130561)
6. J. Nagata H. Kijima H. Hatanaka, et al. 2002 Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene Int J Oncol 21 5 1021 1026 12370750 1:CAS:528:DC%2BD38XosFSrsbo%3D
7. C. Ramachandran L.L. Wellham 2003 Effect of MDR1 phosphorothioate antisenseoligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts Anticancer Res 23 3B 2681 2690 12894558 1:CAS:528: DC%2BD3sXmsFyru7c%3D
8. C. Nieth A. Priebsch A. Stege, et al. 2003 Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) FEBS Lett 545 2-3 144 150 12804765 10.1016/S0014-5793(03)00523-4 1:CAS:528: DC%2BD3sXksVOksb4%3D (Pubitemid 36694691)
9. G.J. Hannon J.J. Rossi 2004 Unlocking the potential of the human genome with RNA interference Nature 431 7006 373 378 10.1038/nature02870 (Pubitemid 39265678)
10. Y.Z. Luan L. Li D. Li, et al. 2004 Development of five kinds of drug-resistant ovarian cancer cell lines and expression of partial resistance-related genes Chin J Obstet Gynecol (Chinese) 39 6 403 407
11. M.M. Gottesman T. Fojo S.E. Bates 2002 Multidrug resistance in cancer: Role of ATP-dependent transporters Nat Rev Cancer 2 1 48 58 11902585 10.1038/nrc706 1:CAS:528:DC%2BD38XhvF2jtL8%3D
12. D.S. Schwarz G. Hutvagner T. Du, et al. 2003 Asymmetry in the assembly of the RNAi enzyme complex Cell 115 2 199 208 14567917 10.1016/S0092-8674(03) 00759-1 1:CAS:528:DC%2BD3sXosFCqsLo%3D (Pubitemid 37329583)
13. H. Lage 2006 MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance Curr Drug Targets 7 7 813 821 16842213 10.2174/138945006777709566 1:CAS:528:DC%2BD28Xms1Crsr0%3D
14. S. Matsukura P.A. Jones D. Takai 2003 Establishment of conditional vectors for hairpin siRNA knockdowns Nucl Acids Res 31 15 e77 12888529 10.1093/nar/gng077
15. M. Stevenson 2004 Therapeutic potential of RNA interference N Engl J Med 351 17 1772 1777 15496626 10.1056/NEJMra045004 (Pubitemid 39383212)
16. G. Sui C. Soohoo E.I.B. Affar, et al. 2002 A DNA vector based RNAi technology to suppress gene expression in mammalian cells PNAS 99 8 5515 5520 11960009 10.1073/pnas.082117599 1:CAS:528:DC%2BD38XjtFKltrg%3D (Pubitemid 34411580)
17. S.M. Elbashir W. Lendeckel T. Tuschl 2001 RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 15 2 188 200 11157775 10.1101/gad.862301 1:CAS:528:DC%2BD3MXhvVOjtbg%3D (Pubitemid 32107664)
18. S. Lu X. Wang L. Cai, et al. 2007 Inhibition of MDR1 gene by hairpin siRNA to reversal of multi-drug resistance in ovarian cancer cells Chin J Obstet Gynecol (Chinese) 42 4 60 62
19. G.D. Pan J.Q. Yang L.N. Yan, et al. 2009 Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro World J Gastroenterol 15 4 431 440 19152447 10.3748/wjg.15.431 1:CAS:528:DC%2BD1MXisVSmt78%3D
20. U. Stein W. Walther A. Stege, et al. 2008 Complete in vivo reversal of the multidrug resistance phenotype by Jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA Molecular Therapy 16 1 178 186 17878902 10.1038/sj.mt.6300304 1:CAS:528:DC%2BD2sXhsVKku7%2FL
21. S. Lu X. Wang L. Xiao, et al. 2007 Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter Cancer Biology Therapy 6 3 397 404 17471022 1:CAS:528:DC%2BD2sXhtVeqsbvI (Pubitemid 47328308)
22. Y. Yang Z. Wang M. Li, et al. 2009 Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells J Huazhong Univ Sci Technolog Med Sci 29 2 239 242 19399413 1:CAS:528: DC%2BD1MXltVylsb4%3D